Company press releases

Displaying 51 - 68 of 68 results
Released Company Title Industry Topic
01 Apr 2022
08:47 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 21 Million 20103010 Biotechnology Change in Capital
31 Mar 2022
17:45 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Launches Capital Increase by Way of Private Placement 20103010 Biotechnology Change in Capital
07 Mar 2022
07:00 CET 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference 20103010 Biotechnology Meetings / events
28 Feb 2022
01:00 CET 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with Alzheimer's Disease 20103010 Biotechnology Other subject
04 Jan 2022
07:00 CET 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Participate in Upcoming Investor Conferences 20103010 Biotechnology Meetings / events
22 Dec 2021
07:00 CET 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Receives FDA Fast Track Designation for Varoglutamstat in Early Alzheimer's Disease 20103010 Biotechnology Other subject
04 Nov 2021
07:00 CET 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q3 2021 Financial Results and Highlights Operational Progress 20103010 Biotechnology Other subject
01 Nov 2021
07:00 CET 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Third Quarter 2021 Financial Results on November 4, 2021 20103010 Biotechnology Other subject
18 Oct 2021
07:00 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Business and Progress of Varoglutamstat Clinical Development in Alzheimer's Disease 20103010 Biotechnology Trends / Analyses
21 Sep 2021
07:00 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2021 Financial Results and Operational Progress 20103010 Biotechnology Commercial results
14 Sep 2021
07:00 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Publish its Financial Results for H1 2021 and Operational Progress 20103010 Biotechnology Other subject
09 Sep 2021
16:41 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference 20103010 Biotechnology Meetings / events
29 Jun 2021
01:11 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Financial Guidance 20103010 Biotechnology Other subject
29 Jun 2021
01:03 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China 20103010 Biotechnology Alliances and agreements
28 Jun 2021
18:00 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V. 20103010 Biotechnology General meeting / Board Meeting
25 Jun 2021
07:00 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Financial Results for the First Quarter of 2021 and Provides Corporate Update 20103010 Biotechnology Commercial results
31 May 2021
18:00 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Reschedules Reporting of 1st Quarter 2021 and Provides Update for Annual General Meeting of Shareholders 20103010 Biotechnology Other subject
17 May 2021
07:00 CEST 		VIVORYON THERAPEUTICS N.V. Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Announces Notice of its Annual General Meeting of Shareholders to be Held on June 28, 2021 20103010 Biotechnology General meeting / Board Meeting